Mentions Of Family History In DTC Ads Catch Hold, Study Finds
This article was originally published in The Pink Sheet Daily
Respondents showed a strong intention to think about lifestyle changes to avoid diseases with family risk factors as well as seek medications.
You may also be interested in...
Industry should be prepared for the fight over user fees for direct-to-consumer advertising to be revived during the fifth round of reauthorization of the Prescription Drug User Fee Act
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
With an unrestricted label and once-daily dosing, rivaroxaban will do battle with Boehringer-Ingelheim's dabigatran, which is dosed twice a day but can claim superior efficacy to warfarin in the atrial fibrillation population.